About Advanced BioHealing
Advanced BioHealing is a company based in Westport (United States) founded in 2003 was acquired by Shire in May 2011. Advanced BioHealing has raised $33.5 million across 2 funding rounds from investors including Takeda Pharmaceuticals, Canaan and Safeguard Scientifics. Advanced BioHealing operates in a competitive market with competitors including Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others.
- Headquarter Westport, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Advanced Biohealing, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$33.5 M (USD)
in 2 rounds
-
Latest Funding Round
$25.5 M (USD), Series C
Feb 27, 2007
-
Investors
Takeda Pharmaceuticals
& 5 more
-
Employee Count
Not available
-
Acquired by
Shire
(May 17, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Advanced BioHealing
Advanced BioHealing has successfully raised a total of $33.5M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $25.5 million completed in February 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Advanced BioHealing
Advanced BioHealing has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals, Canaan and Safeguard Scientifics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences companies
|
Locked | Locked | Locked | |
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked | |
|
Tech-based companies are invested in by Wheatley Partners.
|
Locked | Locked | Locked |
Investor details for Advanced BioHealing
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Advanced BioHealing
Investment portfolio details for Advanced BioHealing
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Advanced BioHealing
Detailed financials for Advanced BioHealing
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Advanced Biohealing Comparisons
Peer comparison for Advanced BioHealing
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Advanced BioHealing
Advanced BioHealing operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| Locked | Locked | Locked |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| Locked | Locked | Locked |
Noninvasive devices and biologics for wound healing are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for infectious disease
|
Detailed competitors of Advanced BioHealing
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Advanced Biohealing
Complete news archive for Advanced BioHealing
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Advanced BioHealing
Advanced BioHealing was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Advanced BioHealing is headquartered in Westport, United States.
Advanced BioHealing is a funded company, having raised a total of $33.5M across 2 funding rounds to date.
Advanced BioHealing was focused on the commercialization of cell-based and tissue-engineered products. The Companys development pipeline includes a next-generation bioengineered tissue product which is in clinical trials. It was acquired by Shire in May, 2011 and name was changed to Shire Regenerative Medicine. Shire sold the business unit to Organogenesis in 2014.
Advanced BioHealing's top competitors include Ilya Pharma, SanuWave and QBiotics.
Advanced BioHealing has 6 investors. Key investors include Takeda Pharmaceuticals, Canaan, Safeguard Scientifics, Red Abbey, and Wheatley Partners.